Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.68 |
| ▸ | TP53 | P04637 | 2/20 | 0.68 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | TDO2 | P48775 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31045502 | 1.00 | LMNA (0.68) | LMNATP53HTTGABRA1GABRB1 | |
| SCHEMBL10973882 | 0.88 | TP53 (0.55) | LMNATP53HTTGABRA1GABRB1 | |
| SCHEMBL18097894 | 0.85 | TP53 (0.68) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL30399939 | 0.83 | TP53 (0.65) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL15053379 | 0.83 | TP53 (0.65) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL5108877 | 0.83 | TP53 (0.65) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL12197660 | 0.82 | GABRA1 (0.52) | LMNATP53HTTGABRA1GABRB1 | |
| SCHEMBL3899828 | 0.81 | TP53 (1.00) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL13866426 | 0.81 | TP53 (0.63) | LMNATP53HTTMEN1KMT2A | |
| SCHEMBL17069205 | 0.81 | TP53 (0.63) | LMNATP53HTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 665 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5030777-A | Synthesis of 3,5-dichloroalkylbenzene and recovery of 1,3-dichlorobenzene | STANDARD CHLORINE OF DELAWARE, INC. (US) | 1991-07-09 | — | — | US | claimed |
| EP-0090875-B1 | SEPARATION OF 3,5-DICHLOROCUMENE FROM A MIXTURE OF 3,5-DICHLOROCUMENE AND 2,4-DICHLOROCUMENE | THE DOW CHEMICAL COMPANY (US) | 1985-07-31 | — | — | EP | claimed |
| EP-0090875-A1 | Separation of 3,5-dichlorocumene from a mixture of 3,5-dichlorocumene and 2,4-dichlorocumene | THE DOW CHEMICAL COMPANY (US) | 1983-10-12 | — | — | EP | claimed |
| US-4329524-A | Separation of 3,5-dichlorocumene from a mixture of 3,5-dichlorocumene and 2,4-dichlorocumene | THE DOW CHEMICAL COMPANY (US) | 1982-05-11 | — | — | US | claimed |
| US-4104315-A | Process for separating an ar, ar-dihalo-ar-alkylbenzene from an isomeric mixture of ar, ar-dihalo-ar-alkylbenzenes | THE DOW CHEMICAL COMPANY (US) | 1978-08-01 | — | — | US | claimed |
| JP-1319444-A | — | — | None | — | — | JP | disclosed |
| US-12043613-B2 | Inhibitors of SARM1 | DISARM THERAPEUTICS, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| US-12043613-B2 | Inhibitors of SARM1 | DISARM THERAPEUTICS, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| US-12024507-B2 | Compounds as GLP-1R agonists | TERNS PHARMACEUTICALS, INC. (US) | 2024-07-02 | — | — | US | disclosed |
| CN-118271338-A | Organic compound, application thereof and organic electroluminescent device | 北京绿人科技有限责任公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118108741-A | Condensed ring compound, application thereof and organic electroluminescent device | 北京绿人科技有限责任公司 | 2024-05-31 | — | — | CN | disclosed |
| WO-2024044493-A2 | TREATMENT OF REPEAT EXPANSION DISEASE | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-02-29 | — | — | WO | disclosed |
| US-4329524-A | Separation of 3,5-dichlorocumene from a mixture of 3,5-dichlorocumene and 2,4-dichlorocumene | THE DOW CHEMICAL COMPANY (US) | 1982-05-11 | — | — | US | disclosed |
| US-4329524-A | Separation of 3,5-dichlorocumene from a mixture of 3,5-dichlorocumene and 2,4-dichlorocumene | THE DOW CHEMICAL COMPANY (US) | 1982-05-11 | — | — | US | disclosed |
| US-4219570-A | Insect repellents and a method of repelling insects | AJINOMOTO COMPANY, INCORPORATED (JP) | 1980-08-26 | — | — | US | disclosed |
| US-4104315-A | Process for separating an ar, ar-dihalo-ar-alkylbenzene from an isomeric mixture of ar, ar-dihalo-ar-alkylbenzenes | THE DOW CHEMICAL COMPANY (US) | 1978-08-01 | — | — | US | disclosed |
| US-4104315-A | Process for separating an ar, ar-dihalo-ar-alkylbenzene from an isomeric mixture of ar, ar-dihalo-ar-alkylbenzenes | THE DOW CHEMICAL COMPANY (US) | 1978-08-01 | — | — | US | disclosed |
| US-4087473-A | Preferential aliphatic halogenation of ar-substituted alkylbenzenes | THE DOW CHEMICAL COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
| US-4087473-A | Preferential aliphatic halogenation of ar-substituted alkylbenzenes | THE DOW CHEMICAL COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
| US-4059642-A | Preferential alkylation or acylation of meta-disubstituted benzenes | THE DOW CHEMICAL COMPANY (US) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12024507-B2 | Compounds as GLP-1R agonists | GLP1R, GIPR, GCGR | LMNA 2472/4885TP53 3988/4885HTT 780/4885 |
| US-12043613-B2 | Inhibitors of SARM1 | SARM1, SMN1; SMN2, SARNP | LMNA 1340/4885TP53 2807/4885HTT 923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.